Clinical trial
6R-BH4 Pulmonary Arterial Hypertension Study
NCT00435331 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00435331 |
|---|---|
| Title | 6R-BH4 Pulmonary Arterial Hypertension Study |
| Official title | A Phase 1, Multicenter, Open-label, Dose-escalation Study to Evaluate the Safety and Efficacy of 6R-BH4 in Subjects With Pulmonary Arterial Hypertension |
| Lead sponsor | Vanderbilt University, Other |
| Collaborators | National Institutes of Health (NIH) NIH BioMarin Pharmaceutical Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pulmonary Arterial Hypertension |
| Intervention type | Drug |
| Interventions | sapropterin dihydrochloride (6R-BH4) |
| Enrollment | 14 |
| Start date | Mar 1, 2008 |
| Primary completion | Sep 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Feb 14, 2007 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: